| 123Jump Rating: |
|
Underwriters: |
Citi
|
| |
|
|
|
| Status: |
Priced |
|
|
| |
| Address: |
6310 Nancy Ridge Drive Suite 101
San Diego CA 92121 US
|
FiledDate: |
11/06/2009 |
| |
|
|
|
| |
|
Filed Price Range ($): |
$5.00 - $5.00 |
| |
|
|
|
| Telephone: |
858-452-0370 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
858-677-9975 |
Shares Offered (Millions): |
10.00 |
| |
|
|
|
| Websites: |
www.triusrx.com. |
Shares Outstanding (Millions): |
|
| |
|
|
|
| Management: |
Jeffrey Stein - President, CEO, and Director
|
IPO Date: |
09/03/2010
|
| |
David S. Kabakoff - Chairman
|
|
|
| |
John P. Schmid - CFO
|
Final Offer Price ($): |
$5.00 |
| |
|
|
|
| Industry: |
PHARMACEUTICAL PREPARATIONS |
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
36 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value 
